Back
Illumina, Inc. (ILMN)
Life Sciences Tools & ServicesILMN · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$190.22
−1.81%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$5.45
ROE
33.8%
Gross margin
68.3%
Debt/Equity
0.95x
Revenue growth
4.8%
Illumina, Inc. — company intelligence
Earnings surprises
Q1 2026$1.15 vs $1.08 est+6.9%
Q4 2025$1.35 vs $1.25 est+7.6%
Q3 2025$1.34 vs $1.19 est+12.7%
Q2 2025$1.19 vs $1.03 est+15.3%
Analyst consensus · 28 analysts
17 Buy8 Hold3 Sell
Updated Jul 6, 2026
Insider activity · 90 days
11 buys41 sellsnet -987,739 shares
Ullem Scott B.Buy 167 · Jun 30, 2026
Meister Keith A.Buy 142 · Jun 30, 2026
Davies Scott MSell 615 · Jun 25, 2026
Recent SEC filings
4 — Insider transaction reportJul 2, 2026
4 — Insider transaction reportJul 2, 2026
4 — Insider transaction reportJun 25, 2026
Latest news
1 High-Flying Stock with Solid Fundamentals and 2 We Find Risky — Yahoo · 4d ago
Evercore ISI Group Maintains Outperform on Illumina, Raises Price Target to $200 — Benzinga · 4d ago
Should You Continue to Hold ILMN Stock in Your Portfolio? — Yahoo · 1w ago
Prediction: Grail Stock Will Skyrocket to $100 in 1 Year — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Illumina, Inc.
Weekly undervalued picks (like ILMN)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.